Dissociated Responses in Patients with Metastatic Solid Tumors Treated with Immunotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-6901
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Dissociated Responses in Patients with Metastatic Solid Tumors Treated with Immunotherapy ; volume:21 ; number:4 ; day:25 ; month:9 ; year:2021 ; pages:399-406 ; date:12.2021
Drugs in R & D ; 21, Heft 4 (25.9.2021), 399-406, 12.2021
- Creator
-
Vaflard, Pauline
Paoletti, Xavier
Servois, Vincent
Tresca, Patricia
Pons-Tostivint, Elvire
Sablin, Marie-Paule
Ricci, Francesco
Loirat, Delphine
Hescot, Ségolène
Torossian, Nouritza
Bello Roufai, Diana
Kamal, Maud
Borcoman, Edith
Le Tourneau, Christophe
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40268-021-00362-3
- URN
-
urn:nbn:de:101:1-2022012818210476648613
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Vaflard, Pauline
- Paoletti, Xavier
- Servois, Vincent
- Tresca, Patricia
- Pons-Tostivint, Elvire
- Sablin, Marie-Paule
- Ricci, Francesco
- Loirat, Delphine
- Hescot, Ségolène
- Torossian, Nouritza
- Bello Roufai, Diana
- Kamal, Maud
- Borcoman, Edith
- Le Tourneau, Christophe
- SpringerLink (Online service)
Other Objects (12)
CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy
Mixed Response to Immunotherapy in Patients with Metastatic Melanoma
Metastatic Ductal Eccrine Adenocarcinoma with Excellent Response to Immunotherapy
Localized immunotherapy with self-amplifying RNA immunotherapy in murine solid tumor models
Adherence assessment of patients with metastatic solid tumors who are treated in an oncology group practice
Opportunistic infections in patients treated with immunotherapy for cancer
An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors
Spontaneous splenic rupture in patient with metastatic melanoma treated with vemurafenib
Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial
Sarcomatoid urothelial carcinoma of the renal pelvis treated with immunotherapy
Perception of cure among patients with metastatic genitourinary cancer initiating immunotherapy
Survival Analysis in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab
CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy
Mixed Response to Immunotherapy in Patients with Metastatic Melanoma
Metastatic Ductal Eccrine Adenocarcinoma with Excellent Response to Immunotherapy
Localized immunotherapy with self-amplifying RNA immunotherapy in murine solid tumor models
Adherence assessment of patients with metastatic solid tumors who are treated in an oncology group practice
Opportunistic infections in patients treated with immunotherapy for cancer
An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors
Spontaneous splenic rupture in patient with metastatic melanoma treated with vemurafenib
Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial
Sarcomatoid urothelial carcinoma of the renal pelvis treated with immunotherapy
Perception of cure among patients with metastatic genitourinary cancer initiating immunotherapy
Survival Analysis in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab
CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy
Mixed Response to Immunotherapy in Patients with Metastatic Melanoma
Metastatic Ductal Eccrine Adenocarcinoma with Excellent Response to Immunotherapy
Localized immunotherapy with self-amplifying RNA immunotherapy in murine solid tumor models
Adherence assessment of patients with metastatic solid tumors who are treated in an oncology group practice
Opportunistic infections in patients treated with immunotherapy for cancer
An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors
Spontaneous splenic rupture in patient with metastatic melanoma treated with vemurafenib
Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial
Sarcomatoid urothelial carcinoma of the renal pelvis treated with immunotherapy
Perception of cure among patients with metastatic genitourinary cancer initiating immunotherapy